Andrew J. Schwab - Aug 21, 2025 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Signature
/s/ Andrew J. Schwab
Stock symbol
SKYE
Transactions as of
Aug 21, 2025
Transactions value $
-$800,549
Form type
4
Date filed
8/22/2025, 07:07 PM
Previous filing
Jun 27, 2025
Next filing
Sep 15, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schwab Andrew J. Director, 10%+ Owner C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO /s/ Andrew J. Schwab 2025-08-22 0001598549

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SKYE Common Stock Sale -$209K -58.6K -3.49% $3.57 1.62M Aug 21, 2025 By 5AM Ventures II, L.P. F1, F2
transaction SKYE Common Stock Sale -$8.26K -2.31K -3.49% $3.57 64K Aug 21, 2025 By 5AM Co-Investors II, L.P. F1, F3
transaction SKYE Common Stock Sale -$561K -164K -10.12% $3.42 1.46M Aug 22, 2025 By 5AM Ventures II, L.P. F2, F4
transaction SKYE Common Stock Sale -$22.1K -6.47K -10.12% $3.42 57.5K Aug 22, 2025 By 5AM Co-Investors II, L.P. F3, F4
holding SKYE Common Stock 8.17M Aug 21, 2025 By 5AM Ventures VII, L.P. F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.69 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3 The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.59 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.